Literature DB >> 17716883

Acceleration of allograft failure by cytomegalovirus.

Daniel N Streblow1, Susan L Orloff, Jay A Nelson.   

Abstract

A number of human herpesviruses are important opportunistic pathogens that have been associated with increased morbidity and mortality in transplant recipients including human cytomegalovirus (HCMV), HHV6, HHV7, HHV8 as well as HSV-1, VZV. However, HCMV has been linked both epidemiologically and through the use of animal models to the acceleration of acute and chronic allograft rejection. This review will cover the pathophysiology, epidemiology, and mechanisms of CMV-associated disease in the setting of transplantation.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17716883      PMCID： PMC3509935          DOI： 10.1016/j.coi.2007.07.012

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN： 0952-7915            Impact factor:   7.486


  61 in total

1.  Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study.

Authors:  H A Valantine; S Z Gao; S G Menon; D G Renlund; S A Hunt; P Oyer; E B Stinson; B W Brown; T C Merigan; J S Schroeder
Journal:  Circulation       Date:  1999-07-06       Impact factor: 29.690

2.  The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration.

Authors:  D N Streblow; C Soderberg-Naucler; J Vieira; P Smith; E Wakabayashi; F Ruchti; K Mattison; Y Altschuler; J A Nelson
Journal:  Cell       Date:  1999-11-24       Impact factor: 41.582

3.  The immediate early gene products of human cytomegalovirus increase vascular smooth muscle cell migration, proliferation, and expression of PDGF beta-receptor.

Authors:  Y F Zhou; Z X Yu; C Wanishsawad; M Shou; S E Epstein
Journal:  Biochem Biophys Res Commun       Date:  1999-03-24       Impact factor: 3.575

4.  Upregulation of functionally active vascular endothelial growth factor by human cytomegalovirus.

Authors:  Barbara Reinhardt; Peter Schaarschmidt; Andrea Bossert; Anke Lüske; Günter Finkenzeller; Thomas Mertens; Detlef Michel
Journal:  J Gen Virol       Date:  2005-01       Impact factor: 3.891

5.  Alterations in the expression of ELAM-1, ICAM-1 and VCAM-1 after in vitro infection of endothelial cells with a clinical isolate of human cytomegalovirus.

Authors:  S Shahgasempour; S B Woodroffe; H M Garnett
Journal:  Microbiol Immunol       Date:  1997       Impact factor: 1.955

6.  Rat cytomegalovirus-accelerated transplant vascular sclerosis is reduced with mutation of the chemokine-receptor R33.

Authors:  Daniel N Streblow; Craig N Kreklywich; Patricia Smith; Jordana L Soule; Christine Meyer; Michael Yin; Patrick Beisser; Cornelis Vink; Jay A Nelson; Susan L Orloff
Journal:  Am J Transplant       Date:  2005-03       Impact factor: 8.086

7.  Expression of human CXCR2 in murine neutrophils as a model for assessing cytomegalovirus chemokine vCXCL-1 function in vivo.

Authors:  Tim E Sparer; Jennifa Gosling; Thomas J Schall; Edward S Mocarski
Journal:  J Interferon Cytokine Res       Date:  2004-10       Impact factor: 2.607

8.  Elevated serum cytokines are associated with cytomegalovirus infection and disease in bone marrow transplant recipients.

Authors:  A Humar; P St Louis; T Mazzulli; A McGeer; J Lipton; H Messner; K S MacDonald
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

9.  Intercellular adhesion molecule-1 expression in endothelial cells is activated by cytomegalovirus immediate early proteins.

Authors:  L J Burns; J C Pooley; D J Walsh; G M Vercellotti; M L Weber; A Kovacs
Journal:  Transplantation       Date:  1999-01-15       Impact factor: 4.939

10.  Functional analysis of the human cytomegalovirus US28 gene by insertion mutagenesis with the green fluorescent protein gene.

Authors:  J Vieira; T J Schall; L Corey; A P Geballe
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103
View more
  48 in total

Review 1.  Management of cytomegalovirus infection in solid organ transplantation.

Authors:  Camille N Kotton
Journal:  Nat Rev Nephrol       Date:  2010-10-26       Impact factor: 28.314

2.  Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties.

Authors:  Irena Slavuljica; Andreas Busche; Marina Babić; Maja Mitrović; Iva Gašparović; Durđica Cekinović; Elitza Markova Car; Ester Pernjak Pugel; Ana Ciković; Vanda Juranić Lisnić; William J Britt; Ulrich Koszinowski; Martin Messerle; Astrid Krmpotić; Stipan Jonjić
Journal:  J Clin Invest       Date:  2010-11-22       Impact factor: 14.808

3.  Cure My Virus: Hematemesis and Melena in a Transplant Recipient.

Authors:  S Sahni; H Kassam; N Yaghooti; A Birg; D M McCarthy
Journal:  Dig Dis Sci       Date:  2021-02-02       Impact factor: 3.199

4.  Proteomic and phylogenetic coevolution analyses of pM79 and pM92 identify interactions with RNA polymerase II and delineate the murine cytomegalovirus late transcription complex.

Authors:  Travis J Chapa; Yushen Du; Ren Sun; Dong Yu; Anthony R French
Journal:  J Gen Virol       Date:  2017-02-12       Impact factor: 3.891

5.  The Human Cytomegalovirus Trimer and Pentamer Promote Sequential Steps in Entry into Epithelial and Endothelial Cells at Cell Surfaces and Endosomes.

Authors:  Jing Liu; Ted S Jardetzky; Andrea L Chin; David C Johnson; Adam L Vanarsdall
Journal:  J Virol       Date:  2018-10-12       Impact factor: 5.103

6.  Two glycosaminoglycan-binding domains of the mouse cytomegalovirus-encoded chemokine MCK-2 are critical for oligomerization of the full-length protein.

Authors:  Sergio M Pontejo; Philip M Murphy
Journal:  J Biol Chem       Date:  2017-04-21       Impact factor: 5.157

7.  Human cytomegalovirus glycoproteins gB and gH/gL mediate epithelial cell-cell fusion when expressed either in cis or in trans.

Authors:  Adam L Vanarsdall; Brent J Ryckman; Marie C Chase; David C Johnson
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

8.  Scanning Mutagenesis of Human Cytomegalovirus Glycoprotein gH/gL.

Authors:  Eric P Schultz; Jean-Marc Lanchy; Erin E Ellerbeck; Brent J Ryckman
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

9.  Cross-reactivity of herpesvirus-specific CD8 T cell lines toward allogeneic class I MHC molecules.

Authors:  Alexis Morice; Béatrice Charreau; Bérangère Neveu; Sophie Brouard; Jean-Paul Soulillou; Marc Bonneville; Elisabeth Houssaint; Nicolas Degauque
Journal:  PLoS One       Date:  2010-08-12       Impact factor: 3.240

10.  Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex.

Authors:  Annalisa Macagno; Nadia L Bernasconi; Fabrizia Vanzetta; Erica Dander; Antonella Sarasini; Maria Grazia Revello; Giuseppe Gerna; Federica Sallusto; Antonio Lanzavecchia
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.